Argonaute RNA

Bringing novel siRNA drugs into the clinic

  • Biotech
Therapeutics

Member

Active

Status

2015

Founded

Development stage

  • St Philips
    Incubator residents

Argonaute RNA is developing safe, reliable and targeted methods of temporarily silencing genes in different tissue cells. It does this via the proprietary modification of small interfering RNA (siRNA), using a novel stabilisation method to overcome previous obstacles to developing siRNA drugs for healthcare.

Founding team

Key contacts